We are live on ! Find out more
IART icon

Integra LifeSciences
IART

219 hedge funds and large institutions have $1.62B invested in Integra LifeSciences in 2025 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 74 increasing their positions, 77 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

611% more call options, than puts

Call options by funds: $512K | Put options by funds: $72K

5.33% more ownership

Funds ownership: 89.87% → 95.2% (+5.3%)

3% more capital invested

Capital invested by funds: $1.57B → $1.62B (+$44.4M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

4% less repeat investments, than reductions

Existing positions increased: 74 | Existing positions reduced: 77

7% less first-time investments, than exits

New positions opened: 28 | Existing positions closed: 30

2% less funds holding

Funds holding: 223 → 219 (-4)

Holders
219
Holders Change
-4
Holders Change %
-1.79%
% of All Funds
2.94%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
28
Increased
74
Reduced
77
Closed
30
Calls
$512K
Puts
$72K
Net Calls
+$440K
Net Calls Change
-$12.6M

Top Buyers

Rank Fund Capital Flow
1
RCMNY
Rubric Capital Management (New York)
New York
+$47.6M
2
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
+$40.6M
3
Invesco
Invesco
Georgia
+$32.1M
4
DM
Deerfield Management
New York
+$18.7M
5
Millennium Management
Millennium Management
New York
+$9.34M

Top Sellers

Rank Fund Capital Flow
1
Capital Research Global Investors
Capital Research Global Investors
California
-$13.5M
2
Morgan Stanley
Morgan Stanley
New York
-$12M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$9.22M
4
BlackRock
BlackRock
New York
-$9.16M
5
Norges Bank
Norges Bank
Norway
-$8.97M
Name Holding Trade Value Shares
Change 		Change in
Stake
LSA
201
Leonteq Securities AG
Switzerland
$1.01K – – –
PTC
202
Private Trust Company
Ohio
$968 +$1.03K +44 New
T
203
Tidemark
California
$968 +$1.03K +44 New
NA
204
NewEdge Advisors
Louisiana
$880 – – –
GFPC
205
Global Financial Private Client
Florida
$836 – – –
MCM
206
MV Capital Management
Maryland
$770 -$329 -14 -29%
AAP
207
Arax Advisory Partners
Colorado
$726 +$776 +33 New
BFS
208
Bare Financial Services
Pennsylvania
$704 +$752 +32 New
FMII
209
Farmers & Merchants Investments Inc
Nebraska
$638 – – –
SPIA
210
Steward Partners Investment Advisory
New York
$528 – – –
PWMG
211
Prestige Wealth Management Group
New Jersey
$462 – – –
GIA
212
GHP Investment Advisors
Colorado
$440 – – –
SC
213
Stephens Consulting
Michigan
$440 +$470 +20 New
QC
214
Quent Capital
New York
$396 – – –
IA
215
IFP Advisors
Florida
$352 -$1.41K -60 Closed
AWM
216
Activest Wealth Management
Florida
$308 +$306 +13 +1,300%
SS
217
SBI Securities
Japan
$286 +$71 +3 +30%
SAM
218
Smartleaf Asset Management
Massachusetts
$238 -$141 -6 -35%
AF
219
Advisornet Financial
Minnesota
$44 – – –
Norges Bank
220
Norges Bank
Norway
– -$8.97M -395,385 Closed
JGC
221
J. Goldman & Co
New York
– -$3.46M -152,452 Closed
WP
222
Woodline Partners
California
– -$2.51M -110,770 Closed
Connor, Clark & Lunn Investment Management (CC&L)
223
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
– -$1.28M -56,327 Closed
CCIA
224
Campbell & Co Investment Adviser
Maryland
– -$1.27M -55,840 Closed
AG
225
Algert Global
California
– -$1.12M -49,197 Closed
6 7 8
9
10

IART Hedge Fund Activity: Q1 2025 in Review

219 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in Integra LifeSciences (IART) for Q1 2025, worth a combined $1.62B — up 2.8% from $1.57B a quarter earlier.

Sellers outnumbered buyers: 30 funds closed out of IART and 28 opened new positions — a net loss of 2 holders — while 77 trimmed existing stakes and 74 added.

The largest buyer was Rubric Capital Management (New York), adding an estimated $47.6M. The largest seller was Capital Research Global Investors, cutting an estimated $13.5M.

  • 219 institutional investors held Integra LifeSciences (IART) as of Q1 2025, down from 223 in Q4 2024.
  • Funds reported $1.62B of Integra LifeSciences stock for Q1 2025, up 2.8% quarter-over-quarter.
  • 28 funds opened new Integra LifeSciences positions in Q1 2025 and 30 closed out, a net change of -2 holders.
  • The largest Integra LifeSciences buyer in Q1 2025 was Rubric Capital Management (New York), an estimated $47.6M added.
  • The largest Integra LifeSciences seller in Q1 2025 was Capital Research Global Investors, an estimated $13.5M sold.

Based on aggregated 13F filings for Q1 2025.